Clinical Trial Update: Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis

View source ↗

Summary

A retrospective analysis reports long-term outcomes for patients with HER2-amplified metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Zurich | Conditions: ERBB2, Breast Cancer | Status: UNKNOWN